Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Medicenna Therapeutics Corp
T.MDNA
Alternate Symbol(s):
MDNAF
Healthcare
Biotechnology
Medicenna Therapeutics Corp. is a Canada-based clinical-stage immunotherapy company. The Company is focused on the development of selective versions of interleukin-2 (IL-2), interleukin-4 (IL-4) and interleukin-13 (IL-13) Superkines and Empowered Superkines for the treatment of cancer, inflammation and immune-mediated diseases. Its long-acting IL-2 Superkine, MDNA11, is an IL-2 with superior...
CD122 (IL-2 receptor beta) binding without CD25 (IL-2 receptor alpha) affinity, thereby preferentially stimulating cancer-killing effector T cells and NK cells. The Company’s IL-4 Empowered Superkine, bizaxofusp, has been studied in five clinical trials including a Phase IIb trial for recurrent glioblastoma (GBM). The Company’s early-stage Bifunctional SuperKine ImmunoTherapies (BiSKITs) program is designed to enhance the ability of Superkines to treat immunologically cold tumors.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:MDNA)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
Next
(210)
•••
Sunvalley
X
View Profile
View Bullboard History
Comment by
Sunvalley
on Jan 15, 2021 2:42pm
RE:Stock cracking - expect more pain in the short term
No thanks . I,ll hold and buy more later today. Soon to become the front line treatment for lung Cancer it seems. Thanks for trying to take care of me tho. Its obvoious you dont own any shares , so
...more
(34)
•••
peterklein
X
View Profile
View Bullboard History
Post by
peterklein
on Jan 15, 2021 10:26am
Stock cracking - expect more pain in the short term
As predicted, all i have to say is I TOLD YOU SO. MDNA is going down down down! It appears the company is selling lots of shares when the stock price is already low and there is no volume.... very
...more
(210)
•••
Sunvalley
X
View Profile
View Bullboard History
Comment by
Sunvalley
on Dec 28, 2020 12:48pm
RE:GREEN LEAF IN THE FUTURE
Neatly fold your green leaf and tuck it where the sun does not shine. This is a cancer site for a exciting new possible new way of treating that deadly disease .
(210)
•••
Sunvalley
X
View Profile
View Bullboard History
Post by
Sunvalley
on Dec 28, 2020 12:37pm
"Going up" I was trying to say!
Fat finger!
(210)
•••
Sunvalley
X
View Profile
View Bullboard History
Post by
Sunvalley
on Dec 28, 2020 12:34pm
Goint up.
mdna is up $1.03 US on the nazdaq in the states today. Bodes well for the Canadian open in the morning if the price holds up. In my opinion we will eventially see $20.00 to $30.00 price in this stock
...more
(210)
•••
Sunvalley
X
View Profile
View Bullboard History
Post by
Sunvalley
on Dec 19, 2020 11:16am
Anyone....
....could you kindly post the recent report on this board as I cannot seem to access it given my limited ability with computors. Thank you in advance.
(210)
•••
Sunvalley
X
View Profile
View Bullboard History
Comment by
Sunvalley
on Dec 19, 2020 7:57am
RE:RE:Heavy volume today
Thanks for that info Pete. Much appreciated. Must be some heavy hitters taking major positions.
(19)
•••
PeteZerria
X
View Profile
View Bullboard History
Comment by
PeteZerria
on Dec 18, 2020 9:51pm
RE:Heavy volume today
Oppenheimer initiated coverage around midweek, with an Outperform and PT of $12. Interesting that their valuation is based solely on MDNA-11.
(210)
•••
Sunvalley
X
View Profile
View Bullboard History
Post by
Sunvalley
on Dec 18, 2020 5:51pm
Heavy volume today
Anyone have any guesses as to why we traded over a million shares today? No new that I can find.
(210)
•••
Sunvalley
X
View Profile
View Bullboard History
Post by
Sunvalley
on Oct 26, 2020 7:39am
More good news today.
Looks like MDNA is setting new standards in survival rates with their ground breaking treatment. Great news indeed.
(1529)
•••
Pandora
X
View Profile
View Bullboard History
Post by
Pandora
on Oct 15, 2020 8:06pm
MDNA55 Update
Medicenna plans hybrid phase 3 trial for MDNA55 2020-10-15 17:48 ET - News Release Ms. Elizabeth Williams reports MEDICENNA PROVIDES MDNA55 RGBM CLINICAL PROGRAM
...more
(210)
•••
Sunvalley
X
View Profile
View Bullboard History
Comment by
Sunvalley
on Oct 01, 2020 9:02pm
RE:RE:Important meeting.
Judging by the share action today it would appear that the FDA meeting went very well. The market always knows??
(210)
•••
Sunvalley
X
View Profile
View Bullboard History
Comment by
Sunvalley
on Sep 30, 2020 9:10am
RE:Important meeting.
Should be good news coming soon as to what the next phase is. Hopefully commercialization very soon.
(210)
•••
Sunvalley
X
View Profile
View Bullboard History
Post by
Sunvalley
on Sep 29, 2020 10:24am
Important meeting.
Today MDNA meets with the FDA to discuss the best way to go forward to advance their new drug to combat cancer. Could be a blockbuster.
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Multiple High-Grade Gold Hits at the Tonopah Gold Project Including 90 Meters at 2.0 gpt Gold
An Opportunity to Join Pulsar Helium on the Ground in Minnesota for a Historic Reservoir Flow Test
NOI Filed for Drill Program at Lithium/Uranium Project in Nevada
Silvercorp to Acquire Adventus for Implied Consideration of C$0.50 per Share
Meet one of the Strongest Contenders to Lead Canada’s Cannabis Market